Newsroom
Featured News
Image
Patient Voices
March marks Amyloidosis Awareness Month. We sat down with Charles, an 88-year-old retired cardiologist from Massachusetts, who shared what it’s like to diagnose and treat heart disease for decades and then face a diagnosis himself. His experience with transthyretin amyloid cardiomyopathy (ATTR-CM) offers a unique perspective on this underrecognized condition.
Defining Moments
2025 was a defining year for Ionis, hallmarked by our first two independent launches as a commercial stage biotech company. Now, Ionis is poised for another transformative year - at JPM 2026 we shared highlights from the past year and outlined key anticipated milestones.
Image
Patient Voices
Through their stories, families, advocates and experts paint a vivid picture of what life with Angelman syndrome looks like – the obstacles, the triumphs and the moments of strength that define their journeys. They share their experiences navigating the path to diagnosis, the hallmark signs and symptoms of AS and, most importantly, the incredible joy that their children with AS bring to their lives.
Image
Innovation at Work
Hear Dr. Sam Tsimikas, SVP of Global Cardiovascular Development, share how Ionis is redefining cardiometabolic care.
Image
Recent posts
Image
Patient Voices
From Treating ATTR-CM to Living with It: A Conversation with a Cardiologist
Image
Defining Moments
Ionis JPM 2026 Takeaways: Breakthrough Therapies Driving Accelerating Growth
Image
Patient Voices
Behind the Mystery of Angelman Syndrome: A Journey of Resilience and Strength
Image
Patient Voices
Meet Rick: Navigating Life with Familial Chylomicronemia Syndrome (FCS)
Image
Image
People & Impact
Ionis CEO Brett Monia, Ph.D Receives 2025 Lifetime Achievement Award from the Oligonucleotide Therapeutics Society
Image
Image
People & Impact
Ionis’ Holly Kordasiewicz, Ph.D. Recognized as a 2025 Women in Biopharma R&D by Endpoints News
Image
Defining Moments
Following the Science: The Origin Story of a New Therapeutic Approach in HAE
Sign up for investor news alerts
For the latest on Ionis investor news.